BACKGROUND: Neonates with inborn errors of metabolism (IEM) often develop hyperammonemia which, if not corrected quickly, may result in poor neurologic outcomes. As pharmacologic therapy cannot rapidly lower ammonia levels, dialysis is frequently required. Both hemodialysis (HD) and standard-dose continuous renal replacement therapy (CRRT) are effective; however, HD may be followed by post-dialytic ammonia rebound, and standard-dose CRRT may not effect a rapid enough decrease in ammonia levels. CASE-DIAGNOSIS/TREATMENT: We present two cases of IEM-associated neonatal hyperammonemia in which we employed a biphasic, high-dose CRRT treatment strategy, initially using dialysate flow rates of 5,000 mL/h (approximately 40,000 mL/h/1.73 m(2)) in order to rapidly decrease ammonia levels, then decreasing the dialysate flow rates to 500 mL/h (approximately 4,000 mL/h/1.73 m(2)) in order to prevent ammonia rebound. CONCLUSIONS: This biphasic dialytic treatment strategy for neonatal hyperammonemia effected rapid ammonia reduction without rebound and accomplished during a single dialysis run without equipment changes.
BACKGROUND: Neonates with inborn errors of metabolism (IEM) often develop hyperammonemia which, if not corrected quickly, may result in poor neurologic outcomes. As pharmacologic therapy cannot rapidly lower ammonia levels, dialysis is frequently required. Both hemodialysis (HD) and standard-dose continuous renal replacement therapy (CRRT) are effective; however, HD may be followed by post-dialytic ammonia rebound, and standard-dose CRRT may not effect a rapid enough decrease in ammonia levels. CASE-DIAGNOSIS/TREATMENT: We present two cases of IEM-associated neonatal hyperammonemia in which we employed a biphasic, high-dose CRRT treatment strategy, initially using dialysate flow rates of 5,000 mL/h (approximately 40,000 mL/h/1.73 m(2)) in order to rapidly decrease ammonia levels, then decreasing the dialysate flow rates to 500 mL/h (approximately 4,000 mL/h/1.73 m(2)) in order to prevent ammonia rebound. CONCLUSIONS: This biphasic dialytic treatment strategy for neonatal hyperammonemia effected rapid ammonia reduction without rebound and accomplished during a single dialysis run without equipment changes.
Authors: Erlandas Ulozas; Srivasa B Chebrolu; Almothana Shanaah; Tarek M Daoud; David J Leehey; Todd S Ing Journal: Artif Organs Date: 2004-02 Impact factor: 3.094
Authors: Timothy E Bunchman; Gina-Marie Barletta; John W Winters; John J Gardner; Teri L Crumb; Kevin D McBryde Journal: Pediatr Nephrol Date: 2007-02-03 Impact factor: 3.714
Authors: Kevin D McBryde; David B Kershaw; Timothy E Bunchman; Norma J Maxvold; Theresa A Mottes; Timothy L Kudelka; Patrick D Brophy Journal: J Pediatr Date: 2006-06 Impact factor: 4.406
Authors: Joann M Spinale; Benjamin L Laskin; Neal Sondheimer; Sarah J Swartz; Stuart L Goldstein Journal: Pediatr Nephrol Date: 2013-03-08 Impact factor: 3.714
Authors: Gregory M Enns; Susan A Berry; Gerard T Berry; William J Rhead; Saul W Brusilow; Ada Hamosh Journal: N Engl J Med Date: 2007-05-31 Impact factor: 91.245
Authors: Nina Hediger; Markus A Landolt; Carmen Diez-Fernandez; Martina Huemer; Johannes Häberle Journal: J Inherit Metab Dis Date: 2018-03-08 Impact factor: 4.982
Authors: Elizabeth G Ames; Corey Powell; Rachel M Engen; Donald J Weaver; Asif Mansuri; Michelle N Rheault; Keia Sanderson; Uta Lichter-Konecki; Ankana Daga; Lindsay C Burrage; Ayesha Ahmad; Scott E Wenderfer; Kera E Luckritz Journal: J Pediatr Date: 2022-03-28 Impact factor: 6.314